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SUMMARY
Themammalian cochlea is one of the least accessible organs for drug delivery. Systemic administration
of many drugs is severely limited by the blood-labyrinth barrier. Local intratympanic administration
into the middle ear would be a preferable option in this case, and the only option for many newly
emerging classes of drugs, but it leads to the formation of drug concentration gradients along the
extensive, narrow cochlea. The gradients are orders of magnitude and well outside the therapeutic
windows. Here we present an efficient, quick, and simple method of cochlear pumping, through
large-amplitude, low-frequency reciprocal oscillations of the stapes and round window, which can
consistently and uniformly deliver drugs along the entire length of the intact cochlea within minutes
without disrupting the cochlear boundaries. The method should facilitate novel ways of approaching
the treatment of inner ear disorders because it overcomes the challenge of delivering therapeutics
along the entire cochlear length.
INTRODUCTION
Reliable, efficient, and uniform drug delivery to the cochlea remains an unsolved challenge and is a major
barrier to the prevention or treatment of inner ear disorders. The mammalian cochlea is one of the least
accessible organs for drug delivery (Salt and Plontke, 2009; Rivera et al., 2012; El Kechai et al., 2015; Hao
and Li, 2019). Systemic administration of many drugs, notably the most frequently used corticosteroids
and aminoglycoside antibiotics, is severely limited by the blood-labyrinth barrier (Salt and Hirose, 2018).
Direct injection into the cochlea is limited by the requirement for surgery for access and does not guarantee
uniform drug delivery along the cochlea.
Several potential therapeutic compounds to treat inner ear disorders are under clinical investigation.
This comprises old and newly emerging classes of drugs and therapies including corticosteroids, local
anaesthetics, antioxidants, apoptosis inhibitors, neurotransmitters and their antagonists, monoclonal an-
tibodies, growth factors, signaling pathway regulators, and genetic material (see Devare et al., 2018;
Hao and Li, 2019). A recent review identified 43 biotechnology companies currently pursuing experimental
compounds for inner ear therapy (Schilder et al., 2019). All such efforts are, however, restricted by our
inability to reliably deliver such compounds into the cochlea.
Intratympanic administration of drugs (Schuknecht, 1956) relies on their remaining in contact with the
round window (RW) (a membranous opening in the bony wall of the cochlea into the middle ear) long
enough to allow their diffusion into the perilymph of the scala tympani (ST). The ability of drugs to
pass through the RW does not, however, guarantee their effective distribution along the cochlear spiral.
Drug distribution in the ST is limited by the low flow rate of perilymph within the cochlea and by the
cochlear geometry. The longitudinal flow of perilymph in the cochlea has been shown to be relatively
slow, if present at all (Ohyama et al., 1988), and drug distribution in the perilymph is dominated by
passive diffusion. Passive diffusion along the ST is, however, constrained because the cochlea is a rela-
tively long and narrow tube with a cochlear cross-section that decreases gradually from the RW at the
base to the apex.
Direct measurements of the distribution of marker ions and contrasting agents (Saijo and Kimura, 1984; Salt
and Ma, 2001; Haghpanahi et al., 2013), corticosteroids (Hargunani et al., 2006; Plontke et al., 2008; Grewal
et al., 2013; Creber et al., 2018), and antibiotics (Imamura and Adams, 2003; Mynatt et al., 2006; Plontke
et al., 2007) or measurements of the physiological effects of drugs (Chen et al., 2005; Borkholder et al.,
2010) have demonstrated that the concentration of substances applied to the RW is much higher in the
cochlear base than in the apex.
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A large number of methods, including intracochlear administration, cochleostomy, and canalostomy, have
been proposed for solving the problem of uniform drug distribution along the cochlea, but only two current
strategies address this problem without breaching the boundaries of the intact cochlea (e.g., see El Kechai
et al., 2015). The first strategy relies on retaining drugs in contact with the RW to allow drug diffusion into
the cochlear apex. Notable examples of devices designed for this purpose include microwicks, osmotic
pumps, etc. Hydrogel-based drug delivery systems also allow retention of therapeutics in the middle ear
in contact with the RW. The problem with this strategy is that retention of drugs at the RW leads to their
establishing steady-state concentration gradients along the cochlea, which depend on the relationship
between diffusion and clearing (Salt and Ma, 2001; Sadreev et al., 2019), but the base-to-apex gradients
can still be very pronounced.
The second strategy, although relatively non-invasive to the cochlea, requires development of more complex
drug formulations. The technique employs drug-loaded nanoparticles, which could be used to take advantage
of the anatomical and cellular features of the cochlea, which enable drug uptake through routes and pathways
other than the ST route (Buckiova´ et al., 2012;Glueckert et al., 2018).Magnetically driven, drug-loadedmagnetic
nanoparticle can also be actively distributed along the entire cochlea (Ramaswamy et al., 2017).
Here we demonstrate that cochlear pumping (CP), through pressure oscillations in the ear canal at fre-
quencies low enough to avoid damage to the cochlear sensory apparatus, can consistently and uniformly
deliver drugs along the entire length of the intact cochlea within minutes without disrupting the cochlear
boundaries.
RESULTS
Cochlear Pumping at Low Frequencies Does Not Cause Elevation of Hearing Thresholds
When inaudible low-frequency air pressure oscillations are presented at the ear canal, they are transmitted
to the stapes, which causes back and forth cochlear fluid movements through the scala vestibuli (SV) and ST
coupled via the helicotrema. The RWworks as a pressure relief valve during thesemovements andmoves in
counter phase with the stapes because the cochlear bony wall and fluid are poorly compressible. The low-
frequency pressure changes within the cochlea are, however, shunted by the helicotrema and do not cause
excitation of the traveling wave and stimulation of the sensory epithelium. In fact, shunting of low-
frequency perilymph flow, which occurs, for example, during themiddle ear muscle reflex, thereby prevent-
ing cochlear overstimulation, is the previse role of the helicotrema (von Be´ke´sy, 1960). The high-frequency
slope of the helicotrema mechanical filter is not, however, infinitely steep (6 dB/octave in guinea pigs and
12 dB/octave in humans; Marquardt et al., 2007) and the choice of CP frequency for drug delivery is critical
to prevent cochlear damage. In our experiments, low-frequency air pressure oscillations applied to the ear
canal at 4 Hz, which caused large-amplitude (80 mm peak-to-peak) stapes displacement (see Transparent
Methods), did not elevate the threshold of the compound action potential (CAP) of the auditory nerve
(Figure 1A).
Cochlear Pumping Promotes Even Distribution of Drugs along the Cochlear Spiral
The ability to distribute drugs uniformly along the entire cochlear spiral using relatively large, low-
frequency periodic displacement of fluid in the ST and SV was demonstrated in our experiments with appli-
cation of salicylate to the RW. Salicylate readily passes through the RW (Borkholder et al., 2014; Sadreev
et al., 2019). To monitor salicylate diffusion along an intact guinea pig cochlea in vivo, we utilized the sup-
pressive effect of salicylate on cochlear amplification by blocking the outer hair cell somatic motility (Russell
and Schauz, 1995; Hallworth, 1997). We measured the elevation of the CAP thresholds caused by salicylate
at different frequencies, which, due to cochlear tonotopicity, corresponds to different distances from the
RW (Greenwood, 1990).
Salicylate did not cause elevation of the CAP threshold responses for frequencies below 5 kHz, which cor-
responds to about 45% of the total cochlear length from the base, when it diffused through the cochlea
passively (Sadreev et al., 2019). The calculated gradient of base-to-apex salicylate concentration was about
13 orders of magnitude. When, however, placement of salicylate solution on the RW was followed by CP,
i.e., by 5-min cycles of large-amplitude (80 mm peak-to-peak), low-frequency (4 Hz) stapes movements
caused by pressure oscillations in the ear canal, the CAP threshold was elevated throughout the entire
1–30 kHz frequency range tested (Figures 1B, 2, and 3). This corresponds to about 75% of the total cochlear
length from the base (Greenwood, 1990). Partial recovery of the CAP thresholds after washing out salicylate
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from the RW (Figure 1B) provided confirmation that the integrity of the sensory cells was preserved and the
threshold elevation after joint salicylate application and CP was not caused by the low-frequency pressure
oscillations (Figure 1A).
The technique had no observable influence, compared with passive diffusion, on responses to RW salicy-
late application for locations close to the RW at the base of the cochlea (Figure 2, 27 kHz). CP, however, led
to more rapid threshold elevation for locations that were distal and apical to the RW, even if the maximal
threshold elevations were similar for both experimental paradigms (Figure 2, 15 kHz). The threshold eleva-
tion saturated after 4–5 cycles of CP, even for the low frequencies of the most apical locations (Figures 1B
and 2, 1–3 kHz) where passive diffusion produced no effect. Smaller threshold elevations at low frequencies
were due only to the reduced contribution of cochlear amplification to cochlear responses at these fre-
quencies (Sadreev et al., 2019; Robles and Ruggero, 2001) and, in fact, reached almost maximal possible
elevations for those frequencies (Figure 3).
DISCUSSION
A stapes displacement of 80 mm in our experiments corresponds to 1.6 mm linear displacement of the fluid
in the apical parts of ST, because in guinea pigs the apical ST cross-sectional area is almost 20 times smaller
(Thorne et al., 1999) than the stapes area (Sim et al., 2013) and both the cochlear bony wall and fluid are
poorly compressible. Therefore, although salicylate effect in the most apical 25% of the cochlear length
was not measured due to poor hearing sensitivity of guinea pigs below 1 kHz, most of the fluid in this region
was replaced by fluid from more basal regions during a single cycle of CP. Hence, estimates of salicylate
distribution derived for the basal regions are valid for the most apical 25% of the cochlea.
The cochlear bony wall and fluid are poorly compressible. The poor compressibility results in the fluid vol-
ume velocity along the SV and ST being the same. Consequently, fluid linear displacement and velocity are
much higher in the narrow apical parts of the scalae than at the base. Specifically, the apical ST cross-
sectional area in guinea pigs is almost 20 times smaller than in the basal cochlear region (it is almost six
times smaller in humans) (Thorne et al., 1999). This proportional increase in fluid displacement and velocity
cannot alone produce effective drug mixing along the cochlea. It will, however, facilitate mechanisms dis-
cussed below, which can enhance the distribution to the cochlear apex of a drug that originally diffuses
through the RW and oval window into the cochlear base.
The larger fluid linear velocity at the apex is still not sufficient to cause turbulent mixing of drugs. Owing to
the small diameter of the cochlear scalae, the fluid flow along them is dominated by fluid viscosity (i.e., it
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Figure 1. Effect of the CP on the Neural Responses in the
Absence and Presence of Salicylate on the RW
(A) Representative examples of CAP threshold curves in the
presence of CP alone. Pressure oscillations at 4 Hz that caused
80 mm peak-to-peak stapes displacement were applied to the ear
canal during 5 min before each non-zero time point plotted, and the
CAP thresholds were measure during the following 5-min interval
without CP. The legend indicates the cumulative pumping time for
each curve. Solid black line and vertical bars indicate the meanG SD
for all seven curves, each representing a different cumulative
pumping time.
(B) A representative example of CAP threshold elevation when the
same pumping protocol as in (A) was used after the application of
5 mL of 100 mM salicylate solution to the RW at time zero and
recovery of the thresholds after washing out the salicylate. The
frequency of the pure tone acoustic stimulation used for eliciting the
CAP is indicated in the figure legend for each curve.
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occurs at low Reynolds numbers). Thus, the fluid flow is laminar even over the uneven inner surface (Cervo et
al., 2013) of the scalae and turbulent mixing will not contribute to uniform drug distribution. The boundary
layer-driven acoustic streaming (i.e., Rayleigh streaming) can potentially contribute to drug mixing in our
experiments (Boluriaan and Morris, 2003; Squires and Quake, 2005). Its role, however, should not be signif-
icant because the boundary layer thickness in water/perilymph at 4 Hz is comparable with the ST diameter.
Nevertheless, the cochlear helical structure should lead to additional drug mixing due to the formation of
Dean vortexes (e.g., Nivedita et al., 2017) and to chaotic mixing/advection, both transversal and longitudi-
nal, observed for laminar fluid flows in helical pipes (Jones et al., 1989; Nguyen, 2011), which can be further
facilitated by periodic changes of the flow direction (Ottino and Wiggins, 2004). Therefore, under specific
condition of cochlear stimulation, these mechanisms may well be the major factors contributing to the mix-
ing and distribution of drugs along the ST and SV. None of the tentative mechanisms discussed above,
except for acoustic streaming, causes net flow of perilymph along the scalae. We argue, however, that
enhanced drug diffusion along the cochlea in our experiments could be observed without net forward
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Figure 2. Comparison of the Efficiency of the CP Technique and Passive Diffusion in the Distribution of Salicylate
along the Cochlea
Pooled data for experiments with CP (red symbols, five preparations) and passive diffusion (black symbols, five
preparations; Sadreev et al., 2019). Pressure oscillations at 4 Hz were applied to the ear canal during 5min before each red
non-zero time point plotted to cause large-amplitude (80 mm peak-to-peak) stapes movement, and the CAP thresholds
were measured during the following 5-min interval without pressure oscillation. Frequency of acoustic stimulation is
indicated within each panel; 5 mL of 100 mM salicylate solution was applied to the RW at time zero. Solid red lines indicate
mean CP data, and solid black lines indicate 5-point running averages for passive diffusion data. Gray lines near the
horizontal axis indicate statistically significant (p < 0.05, unpaired t test) differences between data for the CP and passive
diffusion within consecutive 10-min intervals. Some of the passive diffusion data have been presented before (Sadreev
et al., 2019).
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motion of perilymph. Namely, we propose that the suggested mechanisms help to achieve more efficient
mixing at the drug solution/pure perilymph borderline. Hence, this borderline moves much faster toward
the apex than it is observed in experiments when only molecular diffusion is involved, which helps to
achieve even drug distribution along the entire cochlea within a relatively short time.
The tentative physical principles that govern the uniform distribution of salicylate along the cochlea are
universal and should be valid for the distribution of an arbitrary substance, including nanoparticles, in
the human cochlea. Salicylate was used in these initial experiments because of its well-documented phys-
iological effect, which allows estimation of the drug distribution along the intact cochlea without sampling
perilymph. It was also used because it challenged the CP method. Salicylate is a difficult drug to distribute
along the cochlea because it is cleared rapidly from the ST (Sadreev et al., 2019). It is anticipated that drugs,
which are better retained in the ST, will be redistributed along the cochlea evenmore quickly and efficiently
(Salt and Ma, 2001; Sadreev et al., 2019).
Limitations of the Study
Although the human cochlea has the same helical structure as the guinea pig cochlea, which should pro-
mote drug mixing due to the mechanisms discussed in the article, there are differences in the geometry of
the cochlea that need to be considered for application of the CP in human patients. The human cochlea is
longer, and the apical decrease in the cross-section of scalae is smaller than in guinea pigs (Thorne et al.,
1999). This may result in longer time required to deliver drugs along the more extensive cochlea where in-
crease in the liner fluid velocity at the apical part is less pronounced. On the other hand, the higher cutoff
frequency and steeper low-frequency slope of the helicotrema’s filter in humans (Marquardt et al., 2007)
would permit the use of higher CP frequencies without damaging the cochlear sensory apparatus. This,
together, with the possibility of using larger stapes displacements, which are limited to 80 mm in guinea
pigs by the crista stapedius, could result in higher CP efficiency.
Although prolonged, high-amplitude, low-frequency stimulation did not cause elevations of hearing
thresholds (Figure 1A), this stimulation might potentially affect the vestibular system, especially the
saccule. In fact, excitation of the saccule enables mice to detect low-frequency sounds, which are outside
the frequency range of their cochleae (Jones et al., 2010). This possibility, however, could not be assessed
under the neurolept anesthetic technique used in the study. Therefore, a thorough safety study of the CP
method is needed for its translation to human patients.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2020.100945.
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Figure 3. Comparison of Frequency Dependence of
the CP and Passive Diffusion Effects
Frequency dependence of the CAP threshold elevation
after 60 min of salicylate application during CP (35 min
of the total pumping time) (mean G SD, n = 5) and its
comparison with the frequency dependence for passive
diffusion (mean G SD, n = 5). Open circles show
maximal increase of the CAP thresholds after complete
block of the cochlear amplifier (mean G SD, n = 3)
(Sadreev et al., 2019). Data for passive diffusion have
been partially presented before (Sadreev et al., 2019).
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 Transparent Methods  
Animals 
Animal preparation and signal generation and recording have been described elsewhere (Burwood et al., 2017). 
Briefly, pigmented guinea pigs of similar weight (350-360 g) and both sexes were anaesthetised with the neurolept 
anaesthetic technique (0.06 mg/kg body weight atropine sulphate s.c., 30 mg/kg pentobarbitone i.p., 500 l/kg 
Hypnorm i.m.). Additional injections of Hypnorm were given every 40 minutes. Additional doses of pentobarbitone 
were administered as needed to maintain a non-reflexive state. The heart rate was monitored with a pair of skin 
electrodes placed on both sides of the thorax. The animals were tracheotomized and artificially respired with a mixture 
of O2/CO2, and their core temperature was maintained at 38C with a heating blanket and a heated head holder.  
All procedures involving animals were performed in accordance with UK Home Office regulations with approval 
from the University of Brighton Animal Welfare and Ethical Review Body. 
Signal generation and recording  
The middle ear cavity of the ear used for the measurements and salicylate application was opened to reveal the RW. 
Compound action potentials (CAPs) of the auditory nerve in response to pure tone stimulation were measured from 
the cochlear bony ridge in the proximity of the RW membrane using Teflon-coated silver wire coupled to laboratory 
designed and built extracellular amplifier (James Hartley). Thresholds of the N1 peak of the CAP at different 
frequencies which corresponds to different distances from the cochlear base (Greenwood, 1990) were estimated 
visually using 10 ms pure tone stimuli at a repetition rate of 10 Hz. 
For acoustic stimulation sound was delivered to the tympanic membrane by a closed acoustic system comprising two 
Bruel and Kjaer 4134 ½” microphones for delivering tones and a single Bruel and Kjaer 4133 ½” microphone for 
monitoring sound pressure at the tympanum. The microphones were coupled to the ear canal via 1 cm long, 4 mm 
diameter tubes to a conical speculum, the 1 mm diameter opening of which was placed about 1 mm from the 
tympanum. The speculum was sealed in the ear canal. The closed sound system was calibrated in situ for frequencies 
between 1 and 50 kHz. Known sound pressure levels were expressed in dB SPL re 210-5 Pa.  
All acoustic stimuli in this work were shaped with raised cosines of 0.5 ms duration at the beginning and at the end of 
stimulation. White noise for acoustical calibration and tone sequences for auditory stimulation were synthesised by a 
Data Translation 3010 board (Measurement Computing Corporation, MA) at 250 kHz and delivered to the 
microphones through low-pass filters (100 kHz cut-off frequency). Signals from the acoustic measuring amplifier 
(James Hartley) were digitised at 250 kHz using the same board and averaged in the time domain. Experimental 
control, data acquisition and data analysis were performed using a PC with programmes written in MATLAB 
(MathWorks, MA). 
Salicylate application  
5 l of 100 mM sodium salicylate solution in Hanks’ Balanced Salt Solution were placed on the RW using pipettes. 
The solution was removed from the RW using paper wicks to observe the wash out effect. 
Generation of pressure oscillations in the ear canal  
A modified mouse ventilator MiniVent Type 845 (Hugo Sachs Elektronik, March, Germany) was used to generate 
oscillating air pressure in the ear canal. Output of the ventilator was connected and sealed to the closed acoustic 
system. The stroke frequency (4 Hz) and stroke volume (150 µl) were the same for the all experiments reported. The 
stroke volume was maximized to achieve maximum stapes displacement limited only by the crista stapedius.   
Recording of stapes vibrations  
Stapes vibrations were recorded using a CLV-2534 laser vibrometer (Polytec GmbH, Waldbronn, Germany). The 
laser beam was focussed onto the stapes head. The output voltage from the vibrometer was low-pass filtered at 100 
kHz, with a sensitivity of 5 mm/s/V. Stapes displacement was found by integrating the velocity responses off-line.  
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